找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Hodgkin Lymphoma; A Comprehensive Over Andreas Engert,Anas Younes Book 20152nd edition Springer International Publishing 2015 CD30.Combined

[復(fù)制鏈接]
樓主: controllers
21#
發(fā)表于 2025-3-25 06:37:15 | 只看該作者
Andreas Engert,Anas YounesEvaluates new treatment options for both first-line and relapsed disease.Offers clear guidance on management of special patient groups and Hodgkin survivors.Discusses pathogenesis, clinical evaluation
22#
發(fā)表于 2025-3-25 09:40:43 | 只看該作者
Hematologic Malignancieshttp://image.papertrans.cn/h/image/427831.jpg
23#
發(fā)表于 2025-3-25 12:45:18 | 只看該作者
Prognostic Factors studies of patients treated with different treatment modalities. Survival curves according to Ann Arbor stage for more than 8,000 patients from the United States National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) programme are shown in Fig. 8.1.
24#
發(fā)表于 2025-3-25 16:35:06 | 只看該作者
Principles of Radiation Therapy for Hodgkin Lymphomamotherapy. As the role of RT has transformed over the years from a single modality into a component of combined-modality therapy, the classic principles of RT fields, dose, and technique have fundamentally changed.
25#
發(fā)表于 2025-3-25 23:57:52 | 只看該作者
26#
發(fā)表于 2025-3-26 00:38:25 | 只看該作者
Principles of Chemotherapy in Hodgkin Lymphomaion. Patients with advanced disease represent a minority of those affected by Hodgkin lymphoma. However, these patients represent the group in which the development and effects of chemotherapy are most readily appreciated, since the role of radiation therapy is markedly less than in those with localized disease.
27#
發(fā)表于 2025-3-26 06:51:39 | 只看該作者
The Management of Older Patients with Hodgkin Lymphomaar benefit for older patients, especially for advanced-stage disease. Survival rates for HL patients aged ≥60 years are significantly and disproportionately inferior compared with younger patient populations.
28#
發(fā)表于 2025-3-26 09:38:54 | 只看該作者
Functional Imaging in Hodgkin Lymphomaa) a high chemo- and radiosensitivity of the tumour, (b) an increasing accuracy of staging procedures, and (c) different treatment strategies tailored to well-defined categories of patients with a different risk of treatment failure.
29#
發(fā)表于 2025-3-26 14:48:26 | 只看該作者
30#
發(fā)表于 2025-3-26 17:40:40 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 10:53
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
闽侯县| 武山县| 珲春市| 长治县| 淮阳县| 丰顺县| 巨鹿县| 定安县| 昔阳县| 上犹县| 巴楚县| 舞阳县| 临夏市| 望江县| 习水县| 九龙坡区| 通化市| 西林县| 油尖旺区| 响水县| 会宁县| 瑞金市| 秭归县| 班玛县| 阜城县| 射阳县| 来安县| 河南省| 瑞昌市| 蒙山县| 广安市| 尖扎县| 涪陵区| 兴宁市| 青阳县| 虞城县| 尉氏县| 榆社县| 杂多县| 南平市| 东宁县|